SCHEMBL7466283

SCHEMBL7466283

COC(=O)c1ccc2c3c([nH]c2c1)C(=O)CC3

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.58
PARP1 P09874 3/20 0.58
KDM4E B2RXH2 5/20 0.52
HSD17B10 Q99714 5/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
MAPT P10636 1/20 0.52
ALOX15 P16050 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
ALDH1A1 P00352 7/20 0.50
POLB P06746 1/20 0.50
RAB9A P51151 1/20 0.50
CSNK2A1 P68400 1/20 0.49
HPGD P15428 4/20 0.49
LMNA P02545 1/20 0.49
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
PKM P14618 2/20 0.47
GLA P06280 1/20 0.47
GAA P10253 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7423733 0.92 KDM4E (0.59) KIF11PARP1KDM4EHSD17B10SMN1; SMN2
SCHEMBL6070647 0.82 KDM4E (0.72) KIF11PARP1KDM4EHSD17B10SMN1; SMN2
SCHEMBL31360033 0.80 KDM4E (0.51) KIF11PARP1KDM4EHSD17B10SMN1; SMN2
SCHEMBL6070994 0.79 KIF11 (0.50) KIF11PARP1KDM4EHSD17B10ALDH1A1
SCHEMBL6071240 0.79 MAPK10 (0.66) KIF11KDM4EHSD17B10MAPTALOX15
SCHEMBL25234433 0.78 PARP1 (0.61) KIF11PARP1KDM4EHSD17B10SMN1; SMN2
SCHEMBL30414035 0.78 PARP1 (0.61) KIF11PARP1KDM4EHSD17B10SMN1; SMN2
SCHEMBL30666090 0.78 PARP1 (0.61) KIF11PARP1KDM4EHSD17B10SMN1; SMN2
SCHEMBL29708168 0.77 KIF11 (0.84) KIF11PARP1KDM4EHSD17B10SMN1; SMN2
SCHEMBL4725998 0.77 KIF11 (0.84) KIF11PARP1KDM4EHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed